BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 17439413)

  • 1. CB1 receptor activation in the basolateral amygdala produces antinociception in animal models of acute and tonic nociception.
    Hasanein P; Parviz M; Keshavarz M; Javanmardi K
    Clin Exp Pharmacol Physiol; 2007; 34(5-6):439-49. PubMed ID: 17439413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signaling pathways from cannabinoid receptor-1 activation to inhibition of N-methyl-D-aspartic acid mediated calcium influx and neurotoxicity in dorsal root ganglion neurons.
    Liu Q; Bhat M; Bowen WD; Cheng J
    J Pharmacol Exp Ther; 2009 Dec; 331(3):1062-70. PubMed ID: 19752241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First in vivo evidence for a functional interaction between chemokine and cannabinoid systems in the brain.
    Benamar K; Geller EB; Adler MW
    J Pharmacol Exp Ther; 2008 May; 325(2):641-5. PubMed ID: 18281594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basolateral amygdala CB1 cannabinoid receptors mediate nicotine-induced place preference.
    Hashemizadeh S; Sardari M; Rezayof A
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jun; 51():65-71. PubMed ID: 24468643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CB1 receptors in the preoptic anterior hypothalamus regulate WIN 55212-2 [(4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1ij]quinolin-6-one]-induced hypothermia.
    Rawls SM; Cabassa J; Geller EB; Adler MW
    J Pharmacol Exp Ther; 2002 Jun; 301(3):963-8. PubMed ID: 12023525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinociceptive effect of the cannabinoid agonist, WIN 55,212-2, in the orofacial and temporomandibular formalin tests.
    Burgos E; Pascual D; Martín MI; Goicoechea C
    Eur J Pain; 2010 Jan; 14(1):40-8. PubMed ID: 19318283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid CB(2) receptor activation prevents bronchoconstriction and airway oedema in a model of gastro-oesophageal reflux.
    Cui YY; D'Agostino B; Risse PA; Marrocco G; Naline E; Zhang Y; Chen HZ; Finance O; Rinaldi-Carmona M; Rossi F; Advenier C
    Eur J Pharmacol; 2007 Nov; 573(1-3):206-13. PubMed ID: 17643417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rodent amygdala contributes to the production of cannabinoid-induced antinociception.
    Manning BH; Martin WJ; Meng ID
    Neuroscience; 2003; 120(4):1157-70. PubMed ID: 12927220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anandamide-mediated CB1/CB2 cannabinoid receptor--independent nitric oxide production in rabbit aortic endothelial cells.
    McCollum L; Howlett AC; Mukhopadhyay S
    J Pharmacol Exp Ther; 2007 Jun; 321(3):930-7. PubMed ID: 17379772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in rats.
    Izzo AA; Mascolo N; Pinto L; Capasso R; Capasso F
    Eur J Pharmacol; 1999 Nov; 384(1):37-42. PubMed ID: 10611417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of D1/D2 dopamine receptors within the nucleus accumbens attenuated the antinociceptive effect of cannabinoid receptor agonist in the basolateral amygdala.
    Haghparast A; Ghalandari-Shamami M; Hassanpour-Ezatti M
    Brain Res; 2012 Aug; 1471():23-32. PubMed ID: 22765910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of cannabinoid agonists and apparent pA2 analysis of cannabinoid antagonists in rhesus monkeys discriminating Delta9-tetrahydrocannabinol.
    McMahon LR
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1211-8. PubMed ID: 16943255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoid receptor agonists inhibit Ca(2+) influx to synaptosomes from rat brain.
    Yoshihara S; Morimoto H; Ohori M; Yamada Y; Abe T; Arisaka O
    Pharmacology; 2006; 76(4):157-62. PubMed ID: 16446560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the role of nicotinic acetylcholine receptor subtypes and cannabinoid system in the discriminative stimulus effects of nicotine in rats.
    Zaniewska M; McCreary AC; Przegaliński E; Filip M
    Eur J Pharmacol; 2006 Jul; 540(1-3):96-106. PubMed ID: 16730696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CB1 Cannabinoid Agonist (WIN55,212-2) Within the Basolateral Amygdala Induced Sensitization to Morphine and Increased the Level of μ-Opioid Receptor and c-fos in the Nucleus Accumbens.
    Molaei M; Fatahi Z; Zaringhalam J; Haghparast A
    J Mol Neurosci; 2016 Apr; 58(4):446-55. PubMed ID: 26803309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periaqueductal grey CB1 cannabinoid and metabotropic glutamate subtype 5 receptors modulate changes in rostral ventromedial medulla neuronal activities induced by subcutaneous formalin in the rat.
    de Novellis V; Mariani L; Palazzo E; Vita D; Marabese I; Scafuro M; Rossi F; Maione S
    Neuroscience; 2005; 134(1):269-81. PubMed ID: 15953687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-accumbal NMDA but not AMPA/kainate receptor antagonist attenuates WIN55,212-2 cannabinoid receptor agonist-induced antinociception in the basolateral amygdala in a rat model of acute pain.
    Ghalandari-Shamami M; Hassanpour-Ezatti M; Haghparast A
    Pharmacol Biochem Behav; 2011 Dec; 100(2):213-9. PubMed ID: 21924283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurochemical evidence that stimulation of CB1 cannabinoid receptors on GABAergic nerve terminals activates the dopaminergic reward system by increasing dopamine release in the rat nucleus accumbens.
    Sperlágh B; Windisch K; Andó RD; Sylvester Vizi E
    Neurochem Int; 2009 Jun; 54(7):452-7. PubMed ID: 19428788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocannabinoids in the rat basolateral amygdala enhance memory consolidation and enable glucocorticoid modulation of memory.
    Campolongo P; Roozendaal B; Trezza V; Hauer D; Schelling G; McGaugh JL; Cuomo V
    Proc Natl Acad Sci U S A; 2009 Mar; 106(12):4888-93. PubMed ID: 19255436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the relative potency of SR 141716A and AM 251 as antagonists of various in vivo effects of cannabinoid agonists in C57BL/6J mice.
    McMahon LR; Koek W
    Eur J Pharmacol; 2007 Aug; 569(1-2):70-6. PubMed ID: 17553486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.